{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:18:31Z","timestamp":1783509511019,"version":"3.55.0"},"reference-count":92,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Project of Shanghai Xuhui District Science and Technology","award":["2020-015"],"award-info":[{"award-number":["2020-015"]}]},{"name":"Project of Shanghai Xuhui District Science and Technology","award":["XHLHGG202104"],"award-info":[{"award-number":["XHLHGG202104"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR1043B"],"award-info":[{"award-number":["SHDC2020CR1043B"]}]},{"name":"Young Clinical Scientist Training Program"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>Keratoconus is a progressive ocular disorder characterized by the cornea gradually thinning and protruding into a conical shape, resulting in distorted vision. The underlying pathogenesis of keratoconus is multifactorial and involves a loss of corneal collagen cross-linking, leading to structural instability and the conical deformation of the cornea. Currently, the mainstay treatments for keratoconus include surgical interventions, such as corneal cross-linking, and the use of contact lenses for vision correction. However, there are no approved direct pharmacological treatments available. In this review, we provide an overview of innovative medical therapies that target various pathogenic mechanisms of keratoconus. These treatments aim to enhance collagen cross-linking, reduce corneal degradation, and modulate inflammatory factors. Advances in drug formulations and delivery vehicles have played a significant role in the development of these novel treatments. Some of these therapies are in advanced stages of clinical development, demonstrating promising results, while others remain in preclinical stages. In addition to directly targeting the pathogenesis of keratoconus, preventive measures, such as medical treatments that reduce eye rubbing or mitigate corneal hydrops, have shown potential in halting disease progression and alleviating symptoms. This review aims to update the current landscape of medical treatments for keratoconus, offering insights into future noninvasive therapeutic approaches for managing this condition.<\/jats:p>","DOI":"10.1177\/10807683261431687","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:39:23Z","timestamp":1775702363000},"page":"335-346","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advanced Medicinal Treatment for Keratoconus: A Systematic Review of New Drugs and Formulations"],"prefix":"10.1177","volume":"42","author":[{"given":"Shuang","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Eye &amp; ENT Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Eye &amp; ENT Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Eye &amp; ENT Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Eye &amp; ENT Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taomin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Eye &amp; ENT Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, China."},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China."},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01026-0"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.02.029"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101559"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-vision-121219-081723"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1212314"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/13816810.2014.881507"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2012.09.005"},{"key":"e_1_3_4_9_1","first-page":"4392","article-title":"Effect of IVMED-80 on human cadaver cornea crosslinking","volume":"59","author":"Muddana SKK","year":"2018","unstructured":"8.Muddana SKK, , Ambati BK, , Uehara H, et al. Effect of IVMED-80 on human cadaver cornea crosslinking. Invest Ophthalmol Vis Sci 2018;59:4392.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"e_1_3_4_10_1","first-page":"3","article-title":"The role of tear acidity and Cu-cofactor of lysyl oxidase activity in the pathogenesis of keratoconus]","volume":"127","author":"Avetisov SE","year":"2011","unstructured":"9.Avetisov SE, , Mamikonian VR, , Novikov IA. [The role of tear acidity and Cu-cofactor of lysyl oxidase activity in the pathogenesis of keratoconus]. Vestnik Oftalmol 2011;127(2):3\u20138.","journal-title":"Vestnik Oftalmol"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2015.02.017"},{"key":"e_1_3_4_12_1","first-page":"3359","article-title":"The effect of IVMED-80 eye drops on Lysinonorleucine (LNL) amounts in vivo for treatment of keratoconus","author":"Muddana SK","year":"2019","unstructured":"11.Muddana SK, , Hauritz H, , Burr M, et al. The effect of IVMED-80 eye drops on Lysinonorleucine (LNL) amounts in vivo for treatment of keratoconus. Investigative Ophthalmol Vis Sci 2019:3359.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.63"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.03.016"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113584"},{"key":"e_1_3_4_16_1","first-page":"4255","article-title":"Rescue of lysyl oxidase levels by batimastat and trehalose treatment in human corneal stromal tissue and cell models: Implications for keratoconus therapy","author":"Kiran N","year":"2022","unstructured":"15.Kiran N, , Shetty R, , Khamar P, et al. Rescue of lysyl oxidase levels by batimastat and trehalose treatment in human corneal stromal tissue and cell models: Implications for keratoconus therapy. Investigative Ophthalmol Vis Sci ARVO J 2022:4255.","journal-title":"Investigative Ophthalmol Vis Sci ARVO J"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00900.x"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14831"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.58418"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.686630"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001241"},{"key":"e_1_3_4_22_1","first-page":"4298","article-title":"Analysis of riboflavin levels in aqueous humor and human corneas after oral absorption","author":"Silva LN","year":"2024","unstructured":"21.Silva LN, , Sousa LB, , Oliveira L. Analysis of riboflavin levels in aqueous humor and human corneas after oral absorption. Investigative Ophthalmol Vis Sci ARVO J 2024:4298.","journal-title":"Investigative Ophthalmol Vis Sci ARVO J"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.15761\/ICM.1000160"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-85361-7_20"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7732"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14714"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep04608"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051300"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7605"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13553"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.ijo_3216_21"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/ico.0000000000002475"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.12.16"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1166\/jbt.2019.2026"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1049\/mna2.12079"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s300886"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/ico.0000000000003136"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2022.15406"},{"key":"e_1_3_4_39_1","volume-title":"Lysyl Oxidase Augmentation in Cornea Enhances Collagen Expression: Implications for KC Gene Therapy","author":"Khamar P","year":"2022","unstructured":"38.Khamar P. Lysyl Oxidase Augmentation in Cornea Enhances Collagen Expression: Implications for KC Gene Therapy. Ophthalmology Times; 2022."},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2017.1325910"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2015.05.006"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060974"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01512-7"},{"issue":"6","key":"e_1_3_4_44_1","first-page":"1515","article-title":"Contributions of VSX1 gene to keratoconus","volume":"32","author":"Kalasidou G","year":"2018","unstructured":"43.Kalasidou G, , Frydas I, , Kozei A, et al. Contributions of VSX1 gene to keratoconus. J Biol Regul Homeost Agents 2018;32(6):1515\u20131518.","journal-title":"J Biol Regul Homeost Agents"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040925"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109742"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12035"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2025.05.013"},{"key":"e_1_3_4_49_1","first-page":"504","article-title":"The comparative safety of genipin versus UVA-riboflavin crosslinking of rabbit corneas","volume":"23","author":"Song W","year":"2017","unstructured":"48.Song W, , Tang Y, , Qiao J, et al. The comparative safety of genipin versus UVA-riboflavin crosslinking of rabbit corneas. Mol Vis 2017;23:504\u2013513.","journal-title":"Mol Vis"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2009.11.003"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2016.04.025"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9943458"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.5.6"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08207-3"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78516-x"},{"key":"e_1_3_4_56_1","first-page":"1068","article-title":"Corneal crosslinking with genipin, comparison with UV-riboflavin in ex-vivo model","volume":"18","author":"Avila MY","year":"2012","unstructured":"55.Avila MY, , Gerena VA, , Navia JL. Corneal crosslinking with genipin, comparison with UV-riboflavin in ex-vivo model. Mol Vis 2012;18:1068\u20131073.","journal-title":"Mol Vis"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1997.0410"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/ico.0b013e31821c9b5a"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47059-x"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.06.006"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11509"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49645-8"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/apo.0000000000000555"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2021.0127"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.05.017"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2021.3156"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.09.063"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125435"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202109865"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125064"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0297"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-24803"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.02.009"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/ico.0000000000001228"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03297-w"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5738510"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111424"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102348"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c08486"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj9617"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.1.8"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010233"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(97)00119-7"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10025-1114"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12038"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.11.014"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13786"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.116062"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.01.017"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000037937"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(00)00447-5"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.ijo_2160_23"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2014.333"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683261431687","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683261431687","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683261431687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:51:21Z","timestamp":1783507881000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683261431687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8,1]]}},"alternative-id":["10.1177\/10807683261431687"],"URL":"https:\/\/doi.org\/10.1177\/10807683261431687","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}